Tumor-Specific T Cell Activation by Recombinant Immunoreceptors: CD3 Signaling and CD28 Costimulation Are Simultaneously Required for Efficient IL-2 Secretion and Can Be Integrated Into One Combined CD28/CD3 Signaling Receptor Molecule

Journal of Immunology - United States
doi 10.4049/jimmunol.173.1.695
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists